**China Beats Musk’s Neuralink to Commercial Brain-Chip Implant**
In a groundbreaking medical achievement, Chinese surgeons have successfully implanted a brain-computer interface (BCI) in a patient with limited hand mobility, marking what is being hailed as the world's first commercial procedure using an approved non-invasive device of its kind. The operation took place on Monday at a hospital in Shanghai and is a significant milestone in the field of neurotechnology.
The patient, who suffered a spinal cord injury from a car accident ten years ago, had faced persistent challenges with hand function despite undergoing years of rehabilitation. The innovative procedure involved placing a coin-sized implant, known as NEO, on the surface of the patient’s brain. This device is designed to capture brain signals and transmit them to a computer, which interprets these signals into commands for a robotic glove, thereby allowing the patient to regain some control over hand movements.
According to hospital officials, the surgery proceeded as planned, and the patient is currently recovering with stable vital signs. They reported that the NEO implant successfully captured stable, high-quality brain signals, indicating that the device is functioning as intended.
The NEO implant was developed by Neuracle, a Chinese start-up that received approval from China’s medical regulator in March, enabling it to transition from clinical trials to commercial use in hospitals. This approval positions Neuracle ahead of Elon Musk’s Neuralink in the competitive landscape of brain-computer interface technology. While Neuralink has also conducted human trials and claims to have enrolled 21 participants globally, it has yet to secure full commercial approval in the United States.
The design and approach of the NEO implant set it apart from Neuralink’s technology. NEO is non-invasive, meaning it is placed on the brain's surface without penetrating the tissue. In contrast, Neuralink's implant employs ultra-thin threads that are inserted directly into the brain tissue using a specialized surgical robot. Neuralink's initial product, called Telepathy, aims to enable individuals with paralysis to control computers, smartphones, and other devices through thought alone.
Other companies are also exploring less invasive methods for brain-computer interfaces. For instance, Synchron, a U.S.-based start-up, has developed a device that is inserted through a vein, avoiding the need for open-brain surgery. Additionally, Meta is working on artificial intelligence systems that can translate non-invasive brain scans into text.
Currently, the primary applications of brain-computer interfaces are medical, particularly for patients suffering from paralysis, spinal cord injuries, and severe neurological disorders. However, Elon Musk has expressed ambitious visions for the future, predicting that such technology could eventually replace smartphones. Industry experts have also speculated about potential applications in consumer electronics, robotics, and human augmentation.
As the field of brain-computer interfaces continues to evolve, the successful implantation of the NEO device in Shanghai represents a significant step forward in making advanced neurotechnologies accessible for therapeutic use. The implications of this development could pave the way for further innovations in restoring mobility and enhancing the quality of life for individuals with disabilities.